Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vericiguat for Ventricular Remodeling in Patients With Heart Failure With Reduced Ejection Fraction After Myocardial Infarction

NCT06717204 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.

NCT NCT06717204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vericiguat for Ventricular Remodeling in Patients With Heart Failure With Reduced Ejection Fraction After Myocardial Infarction
Lead sponsor
Qilu Hospital of Shandong University
Phase
Observational
Overall status
Not yet recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
210 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hfref - heart failure with reduced ejection fraction, myocardial infarction (mi)